Therapeutic antiviral-wound healing compositions and methods for preparing and using same

A method for treating an infected wound in a mammal with an antiviral-wound healing composition which comprises administering to a mammal in need thereof:

• a therapeutic antiviral-wound healing composition which comprises:
• (1) a therapeutically effective amount of an antiviral agent;
• and
• (2) a wound healing composition which comprises:
• (a) pyruvate selected from the group consisting of pyruvic acid, pharmaceutically acceptable salts of pyruvic acid, and mixtures thereof;
• (b) an antioxidant;
• and,
• (c) a mixture of saturated and unsaturated fatty acids wherein said fatty acids are those fatty acids required for the resuscitation of injured mammalian cells;
• wherein components a, b, and c are present in synergistic amounts sufficient to synergistically enhance wound healing.

An augmented antiviral-wound healing composition having an enhanced ability to prevent and reduce injury to mammalian cells which comprises:

• (A) a therapeutic antiviral-wound healing composition which comprises:
• (1) a therapeutically effective amount of an antiviral agent;
• and
• (2) a wound healing composition which comprises:
• a) pyruvate selected from the group consisting of pyruvic acid, pharmaceutically acceptable salts of pyruvic acid, and mixtures thereof;
• (b) an antioxidant;
• and,
• (c) a mixture of saturated and unsaturated fatty acids wherein said fatty acids are those fatty acids required for the repair of cellular membranes and resuscitation of mammalian cells:
• wherein components a, b, and c are present in amounts sufficient to synergistically enhance wound healing;
• and,
• (B) a medicament useful for treating wounds.

A method for treating an infected wound in a mammal with an augmented antiviral-wound healing composition which comprises administering to a mammal in need thereof:

• (A) a therapeutic augmented antiviral-wound healing composition which comprises:
• (1) a therapeutically effective amount of an antiviral agent;
• (2) a wound healing composition which comprises:
• (a) pyruvate selected from the group consisting of pyruvic acid, pharmaceutically acceptable salts of pyruvic acid, and mixtures thereof;
• (b) an antioxidant;
• and,
• (c) a mixture of saturated and unsaturated fatty acids wherein said fatty acids are those fatty acids required for the repair of cellular membranes and resuscitation of injured mammalian cells;
• wherein components a, b, and c present in amount sufficient to synergistically enhance wound healing;
• and
• (3) a medicament useful for treating wounds.

An antiviral-wound healing pharmaceutical composition which comprises:

• (A) a therapeutic antiviral-wound healing composition which comprises:
• (1) a therapeutically effective amount of an antiviral agent;
• and
• (2) a wound healing composition which comprises:
• (a) pyruvate selected from the group consisting of pyruvic acid, pharmaceutically acceptable salts of pyruvic acid, and mixtures thereof;
• (b) an antioxidant;
• and,
• (c) a mixture of saturated and unsaturated fatty acids wherein the fatty acids are those fatty acids required for the repair of cellular membranes and resuscitation of mammalian cells;
• wherein components a, b, and c are present in amounts sufficient to synergistically enhance wound healing;
• and,
• (B) a pharmaceutically acceptable carrier selected from the group consisting of pharmaceutical appliances, bioadhesives, and occlusive vehicles.